Exploring new approaches to the treatment of asthma: potential roles for lipoxins and aspirin-triggered lipid mediators.

The prevalence of asthma continues to increase and its optimal treatment remains a challenge. During asthma, leukotrienes and prostaglandins are generated in human airways, leading to bronchoconstriction and airway inflammation. Several pharmaceutical agents are currently available to inhibit the formation or action of these lipid mediators, but asthmatic… CONTINUE READING